Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: 0.3% OPA-15406 ointment; Drug: 1% OPA-15406 ointment Sponsor: Otsuka Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials